David E. Zimmerman

533 total citations
32 papers, 309 citations indexed

About

David E. Zimmerman is a scholar working on Epidemiology, Cardiology and Cardiovascular Medicine and Emergency Medicine. According to data from OpenAlex, David E. Zimmerman has authored 32 papers receiving a total of 309 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 9 papers in Cardiology and Cardiovascular Medicine and 6 papers in Emergency Medicine. Recurrent topics in David E. Zimmerman's work include Emergency and Acute Care Studies (4 papers), Opioid Use Disorder Treatment (4 papers) and Pain Management and Opioid Use (3 papers). David E. Zimmerman is often cited by papers focused on Emergency and Acute Care Studies (4 papers), Opioid Use Disorder Treatment (4 papers) and Pain Management and Opioid Use (3 papers). David E. Zimmerman collaborates with scholars based in United States, Italy and Grenada. David E. Zimmerman's co-authors include Anthony J. Guarascio, Jennifer L. Koehl, Patrick Bridgeman, Jordan R. Covvey, Michael R. Gionfriddo, Robert Pugliese, Bryan D. Hayes, Andrew Smith, John J. Lewin and Victor Cohen and has published in prestigious journals such as Metabolism, Annals of Emergency Medicine and Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy.

In The Last Decade

David E. Zimmerman

27 papers receiving 296 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David E. Zimmerman United States 9 75 74 42 36 35 32 309
John Erramouspe United States 11 48 0.6× 39 0.5× 22 0.5× 9 0.3× 11 0.3× 21 270
Ashish P. Thakrar United States 13 241 3.2× 79 1.1× 4 0.1× 56 1.6× 25 0.7× 32 397
Rita Rubin United States 10 62 0.8× 33 0.4× 3 0.1× 13 0.4× 50 1.4× 38 348
Jeffrey P. Hau Canada 8 120 1.6× 56 0.8× 4 0.1× 3 0.1× 34 1.0× 16 243
Sandra Martin United States 12 105 1.4× 16 0.2× 28 0.7× 11 0.3× 17 0.5× 31 432
Nicholas M. Fusco United States 10 97 1.3× 41 0.6× 48 1.1× 39 1.1× 47 336
Gisele Huf Brazil 14 34 0.5× 44 0.6× 10 0.2× 2 0.1× 21 0.6× 28 481
Rita Laufenberg–Feldmann Germany 13 98 1.3× 43 0.6× 2 0.0× 7 0.2× 28 0.8× 31 564
Greta Bushnell United States 12 102 1.4× 62 0.8× 21 0.5× 1 0.0× 54 1.5× 39 600
Vartika Sharma India 8 38 0.5× 101 1.4× 7 0.2× 2 0.1× 27 0.8× 28 287

Countries citing papers authored by David E. Zimmerman

Since Specialization
Citations

This map shows the geographic impact of David E. Zimmerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Zimmerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Zimmerman more than expected).

Fields of papers citing papers by David E. Zimmerman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David E. Zimmerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Zimmerman. The network helps show where David E. Zimmerman may publish in the future.

Co-authorship network of co-authors of David E. Zimmerman

This figure shows the co-authorship network connecting the top 25 collaborators of David E. Zimmerman. A scholar is included among the top collaborators of David E. Zimmerman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David E. Zimmerman. David E. Zimmerman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stranges, Paul M., Kathleen K. Adams, Qing Ma, et al.. (2025). Pharmacists' contributions to the management of opioid use disorder. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 8(6). 500–510. 1 indexed citations
2.
Feldman, Ryan, Brett Faine, Megan A. Rech, et al.. (2025). CuratED: The emergency medicine pharmacotherapy literature of 2024. The American Journal of Emergency Medicine. 93. 146–153.
3.
Zimmerman, David E., et al.. (2025). Hepatitis B vaccination and immune globulin administration in patients presenting to the emergency department following sexual assault. The American Journal of Emergency Medicine. 97. 188–192.
4.
5.
Acquisto, Nicole M., Zlatan Coralic, Ryan Feldman, et al.. (2024). A national survey of medication utilization for cardiac resuscitation in the emergency department: A survey of emergency medicine pharmacists. American Journal of Health-System Pharmacy. 81(24). 1313–1321.
6.
Koehl, Jennifer L., Caitlin S. Brown, Brett Faine, et al.. (2024). EDucated: The emergency medicine pharmacotherapy literature of 2023. The American Journal of Emergency Medicine. 82. 166–173. 1 indexed citations
7.
Lewis, Alison, Ryan Feldman, David E. Zimmerman, et al.. (2024). Cephalosporins for Outpatient Pyelonephritis in the Emergency Department: COPY-ED Study. Annals of Emergency Medicine. 85(3). 240–248. 2 indexed citations
8.
Sarangarm, Preeyaporn, David E. Zimmerman, Brett Faine, et al.. (2023). UpdatED: The emergency medicine pharmacotherapy literature of 2022. The American Journal of Emergency Medicine. 69. 136–142. 2 indexed citations
9.
Zimmerman, David E., et al.. (2023). Cephalosporins for the treatment of uncomplicated pyelonephritis: A systematic review. Journal of the American Pharmacists Association. 63(5). 1461–1471. 4 indexed citations
10.
Zimmerman, David E., et al.. (2023). The use of buprenorphine to-go packs in the emergency department. The American Journal of Emergency Medicine. 77. 154–157. 1 indexed citations
11.
Brown, Caitlin S., Preeyaporn Sarangarm, Brett Faine, et al.. (2022). The Emergency Medicine Pharmacotherapy Literature of 2021. The American Journal of Emergency Medicine. 60. 88–95. 3 indexed citations
12.
Gionfriddo, Michael R., et al.. (2022). Safety and efficacy of cefiderocol for off‐label treatment indications: A systematic review. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 42(7). 549–566. 8 indexed citations
13.
Zimmerman, David E., Preeyaporn Sarangarm, Caitlin S. Brown, et al.. (2021). Staying InformED: Top emergency Medicine pharmacotherapy articles of 2020. The American Journal of Emergency Medicine. 49. 200–205. 4 indexed citations
14.
Zimmerman, David E., et al.. (2021). Safety and Efficacy of Rivaroxaban and Apixaban in Patients with Increased Body Mass: a Systematic Review. Clinical Drug Investigation. 41(4). 353–369. 8 indexed citations
15.
Zimmerman, David E., et al.. (2018). The effect of body weight on intravenous diltiazem in patients with atrial fibrillation with rapid ventricular response. Journal of Clinical Pharmacy and Therapeutics. 43(6). 855–859. 4 indexed citations
16.
Zimmerman, David E., et al.. (2018). Prescribing trends and revisit rates following a pharmacist-driven protocol change for community-acquired pneumonia in an emergency department†. International Journal of Pharmacy Practice. 27(3). 279–285. 5 indexed citations
17.
Guarascio, Anthony J., et al.. (2017). Evaluation of students' perceptions of the Socrative application versus a traditional student response system and its impact on classroom engagement. Currents in Pharmacy Teaching and Learning. 9(5). 808–812. 45 indexed citations
18.
Chiumente, Marco, et al.. (2015). Burden of Stroke in Italy: An Economic Model Highlights Savings Arising from Reduced Disability following Thrombolysis. International Journal of Stroke. 10(6). 849–855. 5 indexed citations
19.
Hussar, Daniel A. & David E. Zimmerman. (2011). New drugs: Dabigatran etexilate mesylate, fingolimod hydrochloride, and ulipristal acetate. Journal of the American Pharmacists Association. 51(1). 122–126. 2 indexed citations
20.
Beck, Paul A, David E. Zimmerman, & R. Philip Eaton. (1977). Effect of contraceptive steroids on arginine-stimulated glucagon and insulin secretion in women. III. Medroxyprogesterone acetate. Metabolism. 26(11). 1193–1198. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John Erramouspe Breakdown of academic impact, for papers by Ashish P. Thakrar Breakdown of academic impact, for papers by Rita Rubin Breakdown of academic impact, for papers by Jeffrey P. Hau Breakdown of academic impact, for papers by Sandra Martin Breakdown of academic impact, for papers by Nicholas M. Fusco Breakdown of academic impact, for papers by Gisele Huf Breakdown of academic impact, for papers by Rita Laufenberg–Feldmann Breakdown of academic impact, for papers by Greta Bushnell Breakdown of academic impact, for papers by Vartika Sharma
Rankless by CCL
2026